Fosun International
VC Fund
Shanghai, China
Fosun International is a VC fund in Shanghai focused on Health Care and Manufacturing. Fosun International Limited is a Hong Kong-based investment holding company engaged in financial, property, steel, and healthcare businesses. The Company has nine segments. Insurance operates and invests in insurance businesses. Investment is engaged in strategic investment, private equity investment, venture capital investment, and secondarymarket investment.Fosun International Limited was founded in 1992.
- Total investments:
- 121
- Last investment:
- Lead investor:
- 45%
Last updated:
For AI agents: llms.txt
Industries Fosun International invests in
Stages Fosun International invests in
Countries Fosun International invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $1.4M–$16M
- Series B
- $4M–$35M
- Series C
- $4.3M–$97M
Investment Focus
Industry
- Health Care 18 (15%)
- Manufacturing 14 (12%)
- Information Technology 13 (11%)
- FinTech 11 (9%)
- E-Commerce 10 (8%)
Stage
- Series A 31 (26%)
- Series B 30 (25%)
- Series C 15 (12%)
- Funding Round 9 (7%)
- Angel 8 (7%)
Country
- China 78 (64%)
- United States 7 (6%)
- Israel 5 (4%)
- Hong Kong 3 (2%)
- India 2 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Chen Qiyu
Ecutive Director & Co-CEO
|
Ecutive Director & Co-CEO | Total investments: 1 | Find email | |
|
Cong Yonggang
Vice President & Managing Director
|
Vice President & Managing Director | Total investments: 4 | Find email | |
|
Ding Guoqi
SVP & CFO
|
SVP & CFO | Total investments: 0 | Find email | |
|
Qin Xuetang
Executive Director & Senior Vice President
|
Executive Director & Senior Vice President | Total investments: 1 | Find email | |
|
Wang Qunbin
Board of Directors and Co-chairman
|
Board of Directors and Co-chairman | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
DACC's technology links blockchain networks with conventional payment infrastructure, such as China's Cross-Border Interbank Payment System (CIPS), to offer clearing and settlement services for tokenized assets. | $10M / Venture - Series Unknown / May 13, 2026 | |
|
|
Tong Tong Pay has a financial payment system and has developed payment products such as fast payment, online banking payment, account payment, certified payment, and prepaid card payment. It is a financial payment service provider. For inquiries, email, telephone numbers, and physical addresses are available on their website. | Series B / Mar 13, 2026 | |
|
|
Robot++ is a research and development of intelligent robots company. | Series C / Jan 04, 2026 | |
|
|
Maifu Precision is a company focusing on providing high-end automation solutions for the plastics industry, covering injection molding and assembly processes. | $6.8M / Series A / Apr 07, 2025 | |
|
|
Xinglu Technology is a one-stop ToB digital wealth management platform. It offers financial institution clients a complete line of financial products as well as standardized financial technology solutions. | Corporate Round / May 30, 2024 | |
|
|
Xinglu Technology is a one-stop ToB digital wealth management platform. It offers financial institution clients a complete line of financial products as well as standardized financial technology solutions. | Corporate Round / May 30, 2024 | |
|
|
Chunyu Yisheng is a mobile application that enables physicians and their patients to communicate with each other.The application provides physicians with access to their patients’ medical records. Furthermore, it enables the patients to communicate and schedule appointments with the doctors. In addition, it offers reservation line treatmentservices to its users.Chunyu Yisheng was launched in 2011 by Rui Zhang and is based in Beijing. | $29.6M / Venture - Series Unknown / Mar 18, 2024 | |
|
|
Litecore is a manufacturer of optoelectronic devices and processors for broadband, large data centers, and information security. | Venture - Series Unknown / Aug 14, 2023 | |
|
|
Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally. | $97.1M / Series C / Aug 09, 2023 | |
|
|
Brattea is a medical device research and development company. Brattea focuses on the development and commercialization of renal denervation products with indications in hypertension, cancer pain and diabetes. | Series C / Dec 23, 2022 | |
| See all 121 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Fosun International invest in?
Fosun International invests primarily in Health Care, Manufacturing and Information Technology startups, most often at Series A and Series B stage. Most of the 121 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Fosun International's check size?
Fosun International typically joins rounds of $1.4M–$16M at Series A, $4M–$35M at Series B and $4.3M–$97M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Fosun International participates in.
How do I contact Fosun International?
Public channels for Fosun International include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Fosun International?
The team at Fosun International includes Chen Qiyu (Ecutive Director & Co-CEO), Cong Yonggang (Vice President & Managing Director) and Ding Guoqi (SVP & CFO), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!